Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Aggrecan G1-IGD-G2 Domains Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems MAB1220
This item is not returnable.
View return policy
Description
Aggrecan Monoclonal specifically detects Aggrecan in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunoprecipitation.Specifications
Aggrecan | |
Monoclonal | |
LYOPH | |
Western Blot 1 μg/mL, Immunohistochemistry 5-25 μg/mL, Immunoprecipitation 25 μg/mL | |
NP_037359 | |
ACAN | |
Mouse myeloma cell line NS0-derived recombinant human Aggrecan Val20-Gly675 Accession # NP_037359 | |
500 μg | |
Primary | |
Detects human Aggrecan G1-IGD-G2 Domains in Western blots and direct ELISAs. | |
Human | |
Purified |
Western Blot, Immunohistochemistry, Immunoprecipitation | |
179509 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
ACAN, AGC1, AGC1SEDK, aggrecan, aggrecan core protein, Cartilage-specific proteoglycan core protein, Chondroitin sulfate proteoglycan 1, Chondroitin sulfate proteoglycan core protein 1, CSPCP, CSPG1, CSPG1aggrecan 1, CSPGCP, large aggregating proteoglycan, MSK16, MSK16AGCAN, SEDK | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
176 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction